Covered recipient · General Payments record
COREY GITTLEMAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2024
$971.59
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $350.94 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $104.48 | 5 |
| GlaxoSmithKline, LLC. | $67.47 | 3 |
| PFIZER INC. | $56.80 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $41.78 | 2 |
| Biogen, Inc. | $23.80 | 1 |
| ViiV Healthcare Company | $22.79 | 1 |
| Acerta Pharma LLC | $17.36 | 1 |
| Novo Nordisk AS | $16.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.91 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103801900 | CMS |
| ABBVIE INC. | $19.36 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103801902 | CMS |
| ABBVIE INC. | $24.77 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103801904 | CMS |
| ABBVIE INC. | $31.76 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103801906 | CMS |
| ABBVIE INC. | $14.68 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103801908 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.36 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104266683 | CMS |
| Biogen, Inc. | $23.80 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104813727 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.74 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117849695 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.04 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117849697 | CMS |
| GlaxoSmithKline, LLC. | $25.03 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116661177 | CMS |
| GlaxoSmithKline, LLC. | $21.15 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116486461 | CMS |
| GlaxoSmithKline, LLC. | $21.29 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116580385 | CMS |
| Novo Nordisk Inc | $16.46 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096929886 | CMS |
| PFIZER INC. | $16.98 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131917127 | CMS |
| PFIZER INC. | $21.34 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131922215 | CMS |
| PFIZER INC. | $18.48 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131912881 | CMS |
| ViiV Healthcare Company | $22.79 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112828701 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.